Prot #CD-ON-MEDI4736-1161: A Phase 1 Open-label Study of Safety and Tolerability of MEDI4736 in Subjects with Metastatic or Unresectable Melanoma in Combination with Dabrafenib and Trametinib or with Trametinib Alone

Project: Research project

Project Details

StatusFinished
Effective start/end date2/7/14 → 2/7/17

Funding

  • PRA Health Sciences (Prot #CD-ON-MEDI4736-1161 // Prot #CD-ON-MEDI4736-1161)
  • MedImmune, LLC (Prot #CD-ON-MEDI4736-1161 // Prot #CD-ON-MEDI4736-1161)